BARCELONA, SPAIN European countries diverged Wednesday on whether they would push ahead with giving their residents Johnson & Johnson s COVID-19 vaccine after reports of very rare blood clots in a handful of recipients in the United States. While some European Union members put the vaccine on hold as recommended by the American company, Poland, France and Hungary said they would go ahead and administer the doses that had arrived as the EU s 27 nations face continuing pressure to speed up their immunization drives. The Johnson & Johnson vaccine, distributed in Europe by its subsidiary Janssen, is a key part of Europe s vaccination campaign, which has been criticized as sluggish. Of the four vaccines currently approved for use in the EU, J&J s is the only one that requires a single dose to be fully effective. That makes it ideal for hard-to-reach, vulnerable groups, such as those who are homeless or migrant workers.
Johnson & Johnson announced Tuesday that it will delay the distribution of its COVID-19 vaccine in Europe over concerns about a possible link to blood clotting. The lack of the single-dose vaccine might hinder an already-slow vaccine rollout in Europe and put vulnerable populations at risk.
Europe scrambles as J&J vaccine delay deals another blow 680news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 680news.com Daily Mail and Mail on Sunday newspapers.
COVID-Vulnerable Groups Dealt Setback With Vaccine as Europe Largely Halts Johnson & Johnson Shot msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.